Lorann Morse

Lorann Morse has a diverse work history in the field of clinical supply management. Lorann currently holds the position of VP, Clinical Supply at Vir Biotechnology, Inc., where they have been since March 2022. Prior to this, they served as the Sr. Director, Clinical Supply at the same company from December 2020 to March 2022. Before joining Vir Biotechnology, Inc., Lorann worked as the Director of Clinical Supply Chain at CytomX Therapeutics from August 2020 to December 2020. Lorann also has experience as the CEO of Avayle CTS, a company they founded in 2018 to provide commercial drugs for global clinical trials. Lorann has held various director positions in clinical supply management at Nektar Therapeutics and ClinPlan. Lorann has also worked as a consultant in clinical supplies at PRO Unlimited and TargetCW. Additionally, they have experience as the Senior Vice President of Clinigen CTS and the Global Commercial Director at Clinigen Group. Overall, Lorann has a strong background in clinical supply management and significant leadership experience in the industry.

Lorann Morse earned a Bachelor of Interdisciplinary Studies (BIS) degree in Leadership from Villanova University from 2006 to 2010. Prior to that, they completed an Associate of Applied Science (AAS) degree in Med Lab Tech at SUNY Cobleskill from 1988 to 1990.